Beam Therapeutics (BEAM) Financials: Revenue & Earnings

BEAM price $28.40 +3.50 +14.06%

Ticker
BEAM
Price
$28.40
Change
+3.50 +14.06%
Market cap ?
$2.93B
P/E ?
-29.33
Dividend yield ?
0.00%
Beta ?
2.20
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
68
Value
58
Quality
45
Growth
100

Stocklytics score rationale: value 58, quality 45, growth 100.

Financials

201720182019202020212022202320242025
001800024000518440006092000037770900063518000139743000

Beam Therapeutics Inc., founded in 2017 and based in Cambridge, Massachusetts, operates as a pioneering biopharmaceutical firm. Its core mission involves engineering precise genetic remedies to tackle a spectrum of severe human ailments, primarily within the United States. The company's developmental portfolio features several key candidates: BEAM-101 is being advanced to treat both sickle cell disease and beta…

Fair value

BEAM fair value Not meaningful. Price $28.40.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare BEAM

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-03—-1.15—8.75M
2026-08-04-1.18-1.11490.00K16.37M
2026-05-07-0.91-0.8731.74M10.98M
2026-02-24-0.10-1.13114.11M11.67M
2025-11-04-1.10-0.989.70M13.22M
2025-08-05-1.00-1.048.47M11.54M
2025-05-06-1.24-1.117.47M15.52M
2025-02-25-1.09-1.2530.07M16.47M
2024-11-05-1.17-1.1314.27M15.12M
2024-08-06-1.11-1.1311.77M13.73M
2024-05-07-1.21-1.457.41M16.97M
2024-02-271.73-1.01316.19M18.67M
2023-11-08-1.22-1.3717.19M19.91M
2023-08-08-1.08-1.3820.12M18.05M
2023-05-10-1.33-1.3624.21M14.08M
2023-02-28-0.54-1.3220.04M12.71M
2022-11-07-1.56-1.3015.80M7.15M
2022-08-09-1.02-1.0816.65M8.39M
2022-05-09-1.01-1.108.43M44.14M
2022-02-28-0.85-1.0251.07M8.56M
2021-11-08-0.42-0.78763.00K1.13M
2021-08-10-0.95-0.586.00K5.38K
2021-05-11-3.35-0.726.00K13.64K
2021-03-15-0.72-0.706.00K—
2020-11-10-0.69-0.576.00K4.61K
2020-08-12-0.69-0.566.00K4.61K
2020-05-12-1.03-0.556.00K4.51K
2020-03-30-4.47-0.526.00K—
2020-02-07-0.54—6.00K—
2019-06-30-0.51—6.00K—
2019-03-31-0.39———
2018-12-31-0.72———
2018-09-30-1.99———
2018-06-30-8.11———
2018-03-31-8.11———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Quarterly.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2013-11-04$0.232013-11-062013-12-02Quarterly
2013-08-12$0.232013-08-142013-09-03Quarterly
2013-05-06$0.232013-05-082013-06-03Quarterly
2013-02-04$0.232013-02-062013-03-01Quarterly
2012-02-06$0.21—2012-03-01Quarterly

Insider trades

DateInsiderActionSharesPriceValue
2033-06-06Walsh Kathleen EBuy16.53K$34.33567.54K
2026-10-16Evans John M.Buy25.00K$1.0325.75K
2026-10-16Evans John M.Sell25.00K$23.98599.60K
2026-10-16Evans John M.Sell25.00K$1.0325.75K
2026-10-15Evans John M.Sell25.00K$23.57589.15K
2026-10-15Evans John M.Sell25.00K$1.0325.75K
2026-10-01Cavanagh Bethany JSell187$24.414.56K
2026-09-24Ciaramella GiuseppeSell123.41K——
2026-07-27Simon AmySell16.67K$25.74429.04K
2026-06-30Simon AmySell373$34.7312.95K
2026-06-30Evans John M.Buy25.00K$1.0325.75K
2026-06-30Evans John M.Sell23.10K$34.26791.48K
2026-06-30Evans John M.Sell1.90K$34.8466.20K
2026-06-30Evans John M.Sell25.00K$1.0325.75K
2026-06-29Evans John M.Buy18.66K$0.6712.50K
2026-06-29Evans John M.Sell13.42K$35.13471.53K
2026-06-29Evans John M.Sell11.58K$35.91415.82K
2026-06-29Evans John M.Sell6.34K$1.036.53K
2026-06-29Evans John M.Sell18.66K$0.6712.50K
2026-06-26FMR LLCSell251.49K$35.268.87M
2026-06-25FMR LLCSell33.37K$35.121.17M
2026-06-17Ciaramella GiuseppeBuy29.00K$1.0329.87K
2026-06-17Ciaramella GiuseppeBuy6.50K$0.674.36K
2026-06-17Ciaramella GiuseppeSell29.00K$1.0329.87K
2026-06-17Ciaramella GiuseppeSell6.50K$0.674.36K
2026-06-03Shaw ChristiBuy19.68K$29.55581.43K
2026-06-03Walsh Kathleen EBuy19.68K$29.55581.43K
2026-06-03MARAGANORE JOHNBuy19.68K$29.55581.43K
2026-06-03Fishman MarkBuy19.68K$29.55581.43K
2026-06-03Guindo ChirfiBuy19.68K$29.55581.43K
2026-06-03COOPER GRAHAM KBuy19.68K$29.55581.43K
2026-04-01Evans John M.Sell30.08K$24.58739.32K
2026-04-01Simon AmySell6.70K$24.58164.69K
2026-04-01Cavanagh Bethany JSell3.24K$24.5879.69K
2026-04-01Bellon ChristineSell5.96K$24.58146.40K
2026-04-01Ciaramella GiuseppeSell11.81K$24.58290.29K
2026-03-31Bellon ChristineBuy20.00K——
2026-03-31Cavanagh Bethany JBuy20.00K——
2026-03-31Simon AmyBuy31.75K——
2026-03-31Emany Sravan KumarBuy31.75K——
2026-03-31Ciaramella GiuseppeBuy40.00K——
2026-03-31Evans John M.Buy90.00K——
2026-03-31Evans John M.Buy25.00K$0.6716.75K
2026-03-31Evans John M.Sell25.00K$22.76569.09K
2026-03-31Evans John M.Sell25.00K$0.6716.75K
2026-03-30Evans John M.Sell25.00K$22.37559.23K
2026-03-30Evans John M.Sell25.00K$0.6716.75K
2026-02-24Ciaramella GiuseppeSell35.00K$17.00595.00K
2026-02-24Ciaramella GiuseppeBuy35.00K$17.00595.00K
2026-02-24Ciaramella GiuseppeSell35.00K$32.001.12M
2026-01-31Cavanagh Bethany JBuy40.00K$27.621.10M
2026-01-31Ciaramella GiuseppeBuy80.00K$27.622.21M
2026-01-31Emany Sravan KumarBuy63.50K$27.621.75M
2026-01-31Bellon ChristineBuy40.00K$27.621.10M
2026-01-31Evans John M.Buy180.00K$27.624.97M
2026-01-31Simon AmyBuy88.50K$27.622.44M
2026-01-30Evans John M.Buy25.00K$0.6716.75K
2026-01-30Evans John M.Sell22.09K$28.27624.67K
2026-01-30Evans John M.Sell2.91K$29.0084.27K
2026-01-30Evans John M.Sell25.00K$0.6716.75K
2026-01-29Evans John M.Buy19.34K$0.6712.96K
2026-01-29Evans John M.Sell16.33K$29.19476.80K
2026-01-29Evans John M.Sell8.67K$29.74257.78K
2026-01-29Evans John M.Sell5.66K$0.673.79K
2026-01-29Evans John M.Sell19.34K$0.6712.96K
2026-01-22Cavanagh Bethany JSell6.20K$35.00216.93K
2026-01-22Bellon ChristineSell1.37K$34.0046.61K
2026-01-20Cavanagh Bethany JSell3.03K$30.1291.38K
2026-01-15Bellon ChristineSell2.11K$33.6270.98K
2026-01-15Bellon ChristineSell15.96K$34.72554.07K
2026-01-15Bellon ChristineSell559$35.4019.79K
2025-12-31Emany Sravan KumarSell6.29K$27.10170.57K
2025-12-31Bellon ChristineSell1.25K$27.1033.98K
2025-12-31Simon AmyBuy12.50K——
2025-10-27FMR LLCSell459$26.6812.25K
2025-10-06FMR LLCSell1.23M——
2025-10-02Evans John M.Buy25.00K$0.6716.75K
2025-10-02Evans John M.Sell25.00K$24.63615.67K
2025-10-02Evans John M.Sell25.00K$0.6716.75K
2025-10-01Cavanagh Bethany JSell467$24.5311.46K
2025-10-01Bellon ChristineSell373$24.539.15K
2025-10-01Evans John M.Sell25.00K$24.51612.65K
2025-10-01Evans John M.Sell25.00K$0.6716.75K
2025-07-30FMR LLCSell48.37K$20.50991.67K
2025-07-03Simon AmySell876$20.1217.63K
2025-07-01Simon AmySell374$16.946.34K
2025-06-04Walsh Kathleen EBuy33.66K$17.15577.30K
2025-06-04Fishman MarkBuy33.66K$17.15577.30K
2025-06-04Shaw ChristiBuy33.66K$17.15577.30K
2025-06-04Ho CaroleBuy33.66K$17.15577.30K
2025-06-04MARAGANORE JOHNBuy33.66K$17.15577.30K
2025-06-04COOPER GRAHAM KBuy33.66K$17.15577.30K
2025-06-04Guindo ChirfiBuy33.66K$17.15577.30K
2025-04-02Simon AmySell21.00K$17.73372.29K
2025-04-01Bellon ChristineSell5.67K$18.35104.12K
2025-04-01Evans John M.Sell30.66K$18.35562.68K
2025-04-01Ciaramella GiuseppeSell7.43K$18.35136.42K
2025-04-01Cavanagh Bethany JSell3.02K$18.3555.33K
2025-04-01Simon AmySell9.57K$18.35175.54K
2025-03-31FMR LLCOther0——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 286, holders +21 vs prior quarter. Ownership 105.71%.

HolderSharesChangeChange %Value
FMR LLC12.61M156.80K+1.26%432.74M
FARALLON CAPITAL MANAGEMENT, L.L.C.10.24M101.70K+1.00%351.31M
ARK INVESTMENT MANAGEMENT LLC10.23M-1.90M-15.65%351.26M
BLACKROCK, INC.9.00M509.97K+6.01%308.80M
STATE STREET CORP5.83M127.86K+2.24%199.99M
VANGUARD PORTFOLIO MANAGEMENT LLC4.92M350.46K+7.67%168.90M
VANGUARD CAPITAL MANAGEMENT LLC4.60M222.06K+5.07%157.85M
ARCH VENTURE MANAGEMENT, LLC4.54M00.00%155.77M
SUMITOMO MITSUI TRUST GROUP, INC.3.46M-370.54K-9.69%118.58M
AMOVA ASSET MANAGEMENT AMERICAS, INC.3.46M-370.54K-9.69%118.54M
PRICE T ROWE ASSOCIATES INC /MD/3.42M702.01K+25.87%117.21M
KYNAM CAPITAL MANAGEMENT, LP2.84M-841.39K-22.85%97.50M
GEODE CAPITAL MANAGEMENT, LLC2.60M178.37K+7.37%89.14M
DIMENSIONAL FUND ADVISORS LP2.23M71.27K+3.31%76.40M
MORGAN STANLEY1.95M1.30M+200.95%66.96M
CONTRARIUS GROUP HOLDINGS LTD1.61M1.08M+202.66%55.41M
UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC1.55M-101.93K-6.16%53.26M
TWO SIGMA INVESTMENTS, LP1.39M177.37K+14.65%47.64M
CASDIN CAPITAL, LLC1.35M00.00%46.33M
GOLDMAN SACHS GROUP INC1.31M304.32K+30.26%44.96M
REDMILE GROUP, LLC1.16M-73.40K-5.93%39.96M
BNP PARIBAS FINANCIAL MARKETS1.07M367.24K+52.41%36.65M
DEEP TRACK CAPITAL, LP1.00M179.24K+21.84%34.32M
NORTHERN TRUST CORP933.48K107.90K+13.07%32.04M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC885.90K77.47K+9.58%30.40M

Earnings and financials

Beam Therapeutics Inc. (BEAM) trades at $28.40, with a market cap of $2.93B and a trailing P/E of -29.33. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

201720182019202020212022202320242025
001800024000518440006092000037770900063518000139743000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Beam Therapeutics (BEAM) Financials: Revenue & Earnings

BEAM$28.40+3.50 +14.06%

$2.93B

Market Cap

-29.33

P/E

—

Forward P/E

68

Score

Price History